Staphylococcus aureus bacteremia: Recurrence and the impact of antibiotic treatment in a prospective multicenter study

Medicine

Volumn 82, Issue 5, 2003, Pages 333-339

  Chang, Feng Yee ^a,e   Peacock Jr , James E ^b   Musher, Daniel M ^c   Triplett, Patricia ^b   MacDonald, Brent B ^c   Mylotte, Joseph M ^d   O'Donnell, Alice ^d   Wagener, Marilyn M ^a   Yu, Victor L ^a,f  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d ERIE COUNTY MEDICAL CENTER   (United States)

^e TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; NAFCILLIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CATHETER INFECTION; CONTROLLED STUDY; DEVICE INFECTION; DRUG EFFICACY; FEMALE; FOLLOW UP; HOSPITAL INFECTION; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSED FIELD GEL ELECTROPHORESIS; RECURRENT INFECTION; REINFECTION; RISK FACTOR; STAPHYLOCOCCUS AUREUS; VALVULAR HEART DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHI-SQUARE DISTRIBUTION; ELECTROPHORESIS, GEL, PULSED-FIELD; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STATISTICS, NONPARAMETRIC;

EID: 0141925815     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.md.0000091184.93122.09     Document Type: Article

References (25)

1. Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abuser combination therapy. Ann Intern Med. 1988;109:619-624.
2. Chang FY, MacDonald BB, Peacock JE Jr, Musher DM, Triplett P, Mylotte JM, O'Donnell A, Wagener MM, Yu VL. A prospective multicenter study of Staphylococcus aureus bacteremia: Incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore). 2003;82:322-332.
3. Chang FY, Singh N, Gayowski T, Wagener MM, Marino IR. Staphylococcus aureus nasal colonization in patients with cirrhosis: Prospective assessment of association with infection. Infect Control Hosp Epidemiol. 1998;19:328-332.
4. Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteremia: A commentary. Int J Antimicrob Agents. 1999;11:7-12.
5. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings. Am J Med. 1994;96:200-259.
6. Ehni WF, Reller LB. Short-course therapy for catheter-associated Staphylococcus aureus bacteremia. Arch Intern Med. 1989;149:1157-1161.
7. Fowler VG Jr, Kong LK, Corey GR, Gottlieb GS, McClelland RS, Sexton DJ, Gesty-Palmer D, Harrell LJ. Recurrent Staphylococcus aureus bacteremia: Pulsed-field gel electrophoresis findings in 29 patients. J Infect Dis. 1999;179:1157-1161.
8. Fowler VG Jr, Sanders LL, Sexton DJ, Kong L, Marr KA, Gopal AK, Gottlieb G, McClelland RS. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: Experience with 244 patients. Clin Infect Dis. 1998;27:478-486.
9. Garner JS, Jarvis W, Emori TG, Horan TC, Hughes JM. Centers for Disease Control definitions for nosocomial infections. Am J Infect Control. 1988;16:128-140.
10. Goering RV, Winters MA. Rapid method for epidemiological evaluation of gram-positive cocci by field inversion gel electrophoresis. J Clin Microbiol. 1992;30:577-580.
11. Hartstein AI, Mulligan ME, Morthland VH, Kwok RYY. Recurrent Staphylococcus aureus bacteremia. J Clin Microbiol. 1992;30:670-674.
12. Hill PC, Birch P, Chambers S, Drinkovic D, Ellis-Pegler RB, Everts R, Murdock D, Pottumarthy S, Roberts SA, Swager C, Taylor SL, Thomas MG, Wong CG, Morris AJ. Prospective study of 424 cases of Staphylococcus aureus bacteremia: Determination of factors affecting incidence and mortality. Intern Med J. 2001;31:97-103.
13. Jaffe CJ, Vierling JM, Jones EA, Lawley TJ, Frank MM. Receptor specific clearance by the reticuloendothelial system in chronic liver diseases: Demonstration of defective C3b-specific clearance in primary biliary cirrhosis. J Clin Invest. 1978;62:1069-1077.
14. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A, Harrell FE Jr. APACHE III prognostic system: Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619-1636.
15. Korzeniowski O, Sande MA. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. Ann Intern Med. 1982;97:496-503.
16. Lahnborg G, Friman L, Berghem L. Reticuloendothelial function in patients with alcoholic liver cirrhosis. Scand J Gastroenterol. 1981;16:481-489.
17. Malanoski GJ, Samore MH, Pefanis A, Karchmer AW. Staphylococcus aureus catheter-associated bacteremia: Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med. 1995;155:1161-1166.
18. Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim-sulfamethoxzole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med. 1992;117:390-398.
19. Mayhall CG, Medoff G, Marr JJ. Variation in the susceptibility of strains of Staphylococcus aureus to oxacillin, cehalothin, and gentamicin. Antimicrob Agents Chemother. 1976;10:707-712.
20. Musher DM, Fletcher T. Tolerant Staphylococcus aureus causing vertebral osteomyelitis. Arch Intern Med. 1982;142:632-634.
21. Raad II, Sabbagh MF. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: A study of 55 cases and review. Clin Infect Dis. 1992;14:75-82.
22. Rahal JJ Jr, Chan YK, Johnson G. Relationship of staphylococcal tolerance, teichoic acid antibody, and serum bactericidal activity to therapeutic outcome in Staphylococcus aureus bacteremia. Am J Med. 1986;81:43-52.
23. Rimola A, Solo R, Bory F, Arroyo V, Piera C, Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infection and prognosis. Hepatology. 1984;4:53-58.
24. Small PM, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother. 1990;34:1227-1231.
25. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-2239.